HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Deals

M&A, licensing, and major transactions shaping the industry

Lilly Spends Up to $3.8B on Three Vaccine Developers
DealsBriefing
Lilly Spends Up to $3.8B on Three Vaccine Developers
The pharma giant’s latest acquisitions of Curevo, LimmaTech, and Vaccine Company reinforce its pivot from trea…
May 26, 2026
Medtronic inks $650M deal for SPR Therapeutics
DealsFierceBiotech ↗
Medtronic inks $650M deal for SPR Therapeutics
Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company whose flagship product del…
May 24, 2026
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati
DealsPharmaceutical Technology ↗
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati
The tender offer is for €51.29 per share, representing a 13% premium on Recordati’s share price before the tak…
May 22, 2026
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
DealsFiercePharma ↗
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
BMS is the latest large pharma company to make a major bet on AI, announcing a sweeping agreement with Anthrop…
May 22, 2026
Lilly Extends Genetic Medicine Bet With $202M Engage Biologics Buy
DealsBriefing
Lilly Extends Genetic Medicine Bet With $202M Engage Biologics Buy
The Engage acquisition marks another move in Lilly’s ongoing deal blitz, targeting preclinical DNA delivery in…
May 22, 2026
Gilead Sciences acquires Tubulis for $5bn
DealsPharmaceutical Technology ↗
Gilead Sciences acquires Tubulis for $5bn
Gilead Sciences has concluded its acquisition of Germany-based biotechnology company Tubulis in a transaction …
May 22, 2026
Page 1 Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.